Bunkerhill MAC vs cmAngio®
AI Verdict
Choose Bunkerhill MAC if…
Choose Bunkerhill MAC if your primary goal is to identify and quantify mitral annular calcification (MAC) from routine CT scans to assess broader cardiovascular risk. This tool is ideal for integrating MAC findings into a comprehensive care coordination strategy, leveraging its connection with the Carebricks generative AI platform for clinical reasoning and automated follow-up.
View Bunkerhill MAC →Choose cmAngio® if…
Choose cmAngio® if you are looking to leverage existing mammography exams to gain insights into a woman's cardiovascular health by detecting breast arterial calcifications (BAC). This solution is particularly well-suited for integrating BAC identification and reporting into breast screening workflows, offering early cardiovascular risk assessment without additional procedures or radiation.
View cmAngio® →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Bunkerhill MAC | cmAngio® |
|---|---|---|
| Pricing | Contact for pricing | Paid, out-of-pocket |
| Deployment | Cloud-based, integrated with existing EHRs and clinical systems via Carebricks platform. | Cloud-based, integrates with any DICOM-compliant viewer |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cmAngio®Tool B (cmAngiou00ae) explicitly highlights 'Quick and easy installation (less than an hour)' and 'Compatible with any DICOM-compliant viewer,' suggesting a straightforward setup and integration into existing radiology workflows. While Tool A (Bunkerhill MAC) mentions 'seamless integration with existing EHRs and clinical systems,' Tool B's specific claims about rapid installation and broad viewer compatibility provide a stronger indication of immediate usability for radiologists.
Clinical Value
TieBoth tools are FDA-cleared and offer significant clinical value by identifying cardiovascular risk markers from routine imaging (MAC on CT for Tool A, BAC on mammograms for Tool B). Tool A quantifies MAC, potentially offering more granular data, while Tool B processes both FFDM and DBT, broadening its applicability in mammography. Both address critical, often overlooked, cardiovascular risk factors, making their clinical contributions equally valuable in their respective domains.
Pricing & Value
cmAngio®Both tools require direct contact for pricing information. However, Tool B (cmAngiou00ae) explicitly mentions 'Limited-time offers for no-cost implementation and service may be available,' which indicates a potential for greater value or more flexible pricing models for prospective customers. This transparency about potential cost-saving opportunities gives it a slight edge.
Enterprise Readiness
cmAngio®Tool B (cmAngiou00ae) explicitly states it is 'Cybersecure and HIPAA-compliant,' which are crucial assurances for enterprise adoption in healthcare. While Tool A (Bunkerhill MAC) states HIPAA compliance and BAA are 'likely, but not explicitly stated,' Tool B's direct affirmation provides greater confidence in its readiness for secure and compliant enterprise deployment.
Innovation
Bunkerhill MACTool A (Bunkerhill MAC) emphasizes its integration with the 'Carebricks generative AI platform for clinical reasoning and action,' and its tagline is 'Generative AI for clinical reasoning and action.' This suggests a broader and more advanced application of AI beyond mere detection, aiming for automated workflows and deeper clinical insights. Tool B focuses on AI-based detection, which is innovative, but Tool A's generative AI approach appears to be a step further in AI application.
Support & Docs
TieNeither the provided structured facts nor readily available public web searches for 'Bunkerhill Health support documentation' or 'CureMetrix support documentation' offer specific details regarding their support services or documentation. Without this information, it is not possible to distinguish between the two tools on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Bunkerhill MAC | cmAngio® |
|---|---|---|
| AI Algorithm Focus | Detects and quantifies Mitral Annular Calcification (MAC) on CT scans. | Detects, quantifies, and contextualizes Breast Arterial Calcifications (BAC) on mammograms. |
| Imaging Modality | Routine, non-gated chest CT scans. | Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams. |
| Company | Bunkerhill Health | CureMetrix |
| Key Feature Highlight | Integrates with the Carebricks generative AI platform for clinical reasoning and action, supporting automated workflows for follow-up and care coordination. | Provides visualization of BAC location on a scorecard, enables BAC identification and reporting without additional radiation or procedures. |
Videos
Demos, reviews, and walkthroughs featuring Bunkerhill MAC and cmAngio®.